27 February 2024
27 February 2024
Gepotidacin met the trial's primary endpoint in showing non-inferiority to the current standard of treatment.
Akili’s digital therapeutic, EndeavorRx has been approved by the US FDA to treat paediatric patients with ADHD.
As well as a Phase IIb trial of pirepemat, IRLAB is also looking to launch a Phase III trial of its candidate mesdopetam.
The placebo-controlled trial is designed to assess the safety and efficacy of zetomipzomib for treating LN.
AL01211 was found to be generally safe and well-tolerated without causing any serious adverse events.
IceCure’s ProSense system is a minimally invasive cryoablation technology that destroys tumours by freezing, instead of surgical removal.
The trial of ETX101 in children is set to begin later this year.
Bayer’s oral tyrosine kinase inhibitor is currently in a Phase I trial estimated to enrol 460 patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
